• Summary
  • Table Of Content
  • Segmentation
  • Request sample

Electroconvulsive Therapy Market Synopsis:

Electroconvulsive Therapy Market Size Was Valued at USD 16.1 Billion in 2023, and is Projected to Reach USD 20.28 Billion by 2032, Growing at a CAGR of 2.60% From 2024-2032.

The Electroconvulsive Therapy (ECT) market includes the sale and usage of medical devices and therapeutic processes that deliver electric currents to the brain in order to manage several mental health disorders, but mainly MDD, Bipolar Disorder and Schizophrenia. ECT is commonly used as a last resort after a patient has not responded to medication or psychotherapy or when the patient needs to get well urgently. This method of treatment is conducted with certain restrictions and it is important for the fact that it effectively helps to lessen severe manifestations, thus enhancing the psychical well-being and the sphere of life of patients.

The global Electroconvulsive Therapy market shares some of the following trends as a driving force for its growth: The growing incidence of mental disorders. Today depression, anxiety, and other forms of psychopathology have become more widespread, which has caused an increase in the need for efficient therapy forms. As the populace becomes sensitized to the issues surrounding mental health, patients and caregivers are now looking for treatments that start producing the intended results very quickly because conditions such as severe depression or when other treatments have failed are serious illnesses.

The other major factor is the positive technological changes that have occurred within ECT making it safer and more effective to perform. Today ECT equipments are have some useful features such as patient monitoring systems these days ECT has minimum risk factors and its usefulness is proved. Also, new techniques like modified ECT, which uses lesscurrent and less anesthetic, has been developed thus eradicating the pastreligion based stigma and thus is applied frequently by the medics.

Electroconvulsive Therapy Market

Electroconvulsive Therapy Market Trend Analysis:

The increasing integration of technology and innovation in ECT procedures.

  • A recent development in the Electroconvulsive Therapy market is that technological advancement and innovations are adopted in the practice of ECT. One type of ECT comprises of computer assisted equipment that has accurate dosages and monitors the response of the patients in real time is gradually gaining acceptance. These technologies do not only increase the safety of the procedure, but also improve the patients’ outcomes which in turn supports the tray market growth. Also, the use of telemedicine is gradually finding its ways into the treatment of mental disorders because it also entails possibilities of remotely following up with the patient after the ECT treatments.
  • The other developing trend is increasing popularity of ECT among the physicians and the patients. Contrary to its earlier attributions as being a violent therapy, ECT has shifted into the acceptance in some circles of the kinetic treatment as being effective. Camps have been made to alter people’s perception of ECT and success rates achieved in the clinical practice have also influenced the increased use of ECT in several health facilities. The rejection of ECT is decreasing as more mental health practitioners recommend it, and contributing to the growth of the market.

Mental health services are still developing

  • From the mentioned details, this research realizes that the Electroconvulsive Therapy market has many opportunities for the growth, especially within the regions that are still in the developmental stage concerning the provider of mental health services. With a rising focus in mental health disorders in areas like Asia-Pacific and Latin America, people seek the right treatment regimens such as ECT. This demand opens up space for market players to increase their coverage and bring new and better ECT technologies and services that meet these regions’ needs.
  • Furthermore, the research and development activities in order to improve the existing techniques and equipment in ECT market is expected to serve a great opportunity for market in the future. Hitherto, organizations vested with the responsibility of developing ECT devices and methods that ensure optimal safety, efficiency and comfort to patients are most likely to enjoy enhanced competitiveness. This might also pave way for more drug developers for pharmaceuticals and medical devices to merge on how ECT can be incorporated with other modalities of treatment that can enhance the treatment of patients with serious mental disorders.

Electroconvulsive Therapy Market Segment Analysis:

Electroconvulsive Therapy Market is Segmented on the basis of Product type, Technology, Application, End User, and Region

By Product Type, ECT Devices segment is expected to dominate the market during the forecast period

  • The Electroconvulsive Therapy (ECT) market is primarily segmented by product type into three categories: ECT equipment and accessories, and consumables. ECT devices are the main apparatus employed for delivering electrical currents to the head and there are models for unilateral and bilateral therapies each with its advantages. The accessories may comprise electrodes, monitoring devices and equipment used in the administration of anesthesia this gears up the safety of the ECT process. They highlighted consumables as the items that are used during the treatment process to be disposed of after use and include electrodes and other items that must not be used again to avoid cross-contamination. In combination and as part of ECT delivery, both these product types are vital in helping achieve better patient outcomes, and assist those involved in the management of Mental Health issues in the best ways possible.

By Application, Bipolar Disorder segment expected to held the largest share

  • Based on the application, the Electroconvulsive Therapy (ECT) is categorized mainly into major depressive disorder, bipolar disorder, schizophrenia, and other application types. The most common condition for which ECT is used is major depressive disorder because its effectiveness is well documented for patients who had limited response to conventional treatments such as medication and psychotherapy. Bipolar disorder is another major area where FCT is used when the patient is in a highly manic or depressive phase to get the patient’s mood regulated. ECT is also used in schizophrenia especially where patients develop severe flare or keep on having adverse reactions to antipsychotic products. The category of ‘others’ includes a variety of psychiatric and neurological disorders which might improve with ECT: severe anxiousness disorders, catatonic syndrome, treatment-refractory states with various kinds of psychosis or bipolar mood disorders. Such a spec­trum of applications stresses up on the pro­gressive nature of ECT as a curative modality in severe mental ailments.

Electroconvulsive Therapy Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • The market for Electroconvulsive Therapy is at present most concentrated in North America and this region holds the largest share of the global market. Much of the area commendable health care systems, high rate of mental health disorders, and effective psychiatric care centers play a crucial role in this position. Besides, improvement in the understanding and acceptance of ECT both by a mental health professionals and patients has paved way for the development of ECT services in the region.
  • In addition, North America has constant development in technologic discoveries in the medical field, and a remarkable emphasis on mental health. Several investors involved in the ECT market are based in this region, and they believe in the development of new technologies and research to increase the effectiveness and security of the treatment. Increase of coverage and knowledge about mental diseases and the enhanced demand for their treatment should help the North American market to continue its domination in the sphere of Electroconvulsive Therapy.

Active Key Players in the Electroconvulsive Therapy Market:

  • Somatics, LLC (United States)
  • Neurostar, Inc. (United States)
  • Viva Healthcare (United States)
  • MagVenture A/S (Denmark)
  • Korea Electroconvulsive Therapy (South Korea)
  • Ectron (United States)
  • Bramsys (France)
  • Demeditec Diagnostics GmbH (Germany)
  • Fisher & Paykel Healthcare Limited (New Zealand)
  • Electroconvulsive Therapy Corporation (United States)
  • Other Active Players

Electroconvulsive Therapy Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 16.1 Billion

Forecast Period 2024-32 CAGR:

2.60 %

Market Size in 2032:

USD 20.28 Billion

Segments Covered:

By Product Type

  • ECT Devices
  • Accessories
  • Consumables

By Technology

  • Unilateral ECT
  • Bilateral ECT
  • Others

By Application

  • Major Depressive Disorder
  • Bipolar Disorder
  • Schizophrenia
  • Others

By End User

  • Hospitals
  • Clinics
  • Research Institutions

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Advancements in ECT Technology

Key Market Restraints:

  • Stigma Surrounding Electroconvulsive Therapy

Key Opportunities:

  • Innovations in ECT Devices and Techniques

Companies Covered in the report:

  • Somatics, LLC (United States), Neurostar, Inc. (United States), Viva Healthcare (United States), MagVenture A/S (Denmark), Korea Electroconvulsive Therapy (South Korea), Ectron (United States), Bramsys (France), Demeditec Diagnostics GmbH (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Electroconvulsive Therapy Corporation (United States). and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Electroconvulsive Therapy Market by Product Type
 4.1 Electroconvulsive Therapy Market Snapshot and Growth Engine
 4.2 Electroconvulsive Therapy Market Overview
 4.3 ECT Devices
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 ECT Devices: Geographic Segmentation Analysis
 4.4 Accessories
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Accessories: Geographic Segmentation Analysis
 4.5 Consumables
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Consumables: Geographic Segmentation Analysis

Chapter 5: Electroconvulsive Therapy Market by Technology
 5.1 Electroconvulsive Therapy Market Snapshot and Growth Engine
 5.2 Electroconvulsive Therapy Market Overview
 5.3 Unilateral ECT
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Unilateral ECT: Geographic Segmentation Analysis
 5.4 Bilateral ECT
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Bilateral ECT: Geographic Segmentation Analysis
 5.5 Others
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Others: Geographic Segmentation Analysis

Chapter 6: Electroconvulsive Therapy Market by Application
 6.1 Electroconvulsive Therapy Market Snapshot and Growth Engine
 6.2 Electroconvulsive Therapy Market Overview
 6.3 Major Depressive Disorder
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Major Depressive Disorder: Geographic Segmentation Analysis
 6.4 Bipolar Disorder
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Bipolar Disorder: Geographic Segmentation Analysis
 6.5 Schizophrenia
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Schizophrenia: Geographic Segmentation Analysis
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation Analysis

Chapter 7: Electroconvulsive Therapy Market by End User
 7.1 Electroconvulsive Therapy Market Snapshot and Growth Engine
 7.2 Electroconvulsive Therapy Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Clinics
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Clinics: Geographic Segmentation Analysis
 7.5 Research Institutions
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Research Institutions: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Electroconvulsive Therapy Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 SOMATICS LLC (UNITED STATES)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 NEUROSTAR INC. (UNITED STATES)
 8.4 VIVA HEALTHCARE (UNITED STATES)
 8.5 MAGVENTURE A/S (DENMARK)
 8.6 KOREA ELECTROCONVULSIVE THERAPY (SOUTH KOREA)
 8.7 ECTRON (UNITED STATES)
 8.8 BRAMSYS (FRANCE)
 8.9 DEMEDITEC DIAGNOSTICS GMBH (GERMANY)
 8.10 FISHER & PAYKEL HEALTHCARE LIMITED (NEW ZEALAND)
 8.11 ELECTROCONVULSIVE THERAPY CORPORATION (UNITED STATES)
 8.12 OTHER ACTIVE PLAYERS

Chapter 9: Global Electroconvulsive Therapy Market By Region
 9.1 Overview
9.2. North America Electroconvulsive Therapy Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 ECT Devices
  9.2.4.2 Accessories
  9.2.4.3 Consumables
  9.2.5 Historic and Forecasted Market Size By Technology
  9.2.5.1 Unilateral ECT
  9.2.5.2 Bilateral ECT
  9.2.5.3 Others
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Major Depressive Disorder
  9.2.6.2 Bipolar Disorder
  9.2.6.3 Schizophrenia
  9.2.6.4 Others
  9.2.7 Historic and Forecasted Market Size By End User
  9.2.7.1 Hospitals
  9.2.7.2 Clinics
  9.2.7.3 Research Institutions
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
9.3. Eastern Europe Electroconvulsive Therapy Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 ECT Devices
  9.3.4.2 Accessories
  9.3.4.3 Consumables
  9.3.5 Historic and Forecasted Market Size By Technology
  9.3.5.1 Unilateral ECT
  9.3.5.2 Bilateral ECT
  9.3.5.3 Others
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Major Depressive Disorder
  9.3.6.2 Bipolar Disorder
  9.3.6.3 Schizophrenia
  9.3.6.4 Others
  9.3.7 Historic and Forecasted Market Size By End User
  9.3.7.1 Hospitals
  9.3.7.2 Clinics
  9.3.7.3 Research Institutions
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Electroconvulsive Therapy Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 ECT Devices
  9.4.4.2 Accessories
  9.4.4.3 Consumables
  9.4.5 Historic and Forecasted Market Size By Technology
  9.4.5.1 Unilateral ECT
  9.4.5.2 Bilateral ECT
  9.4.5.3 Others
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Major Depressive Disorder
  9.4.6.2 Bipolar Disorder
  9.4.6.3 Schizophrenia
  9.4.6.4 Others
  9.4.7 Historic and Forecasted Market Size By End User
  9.4.7.1 Hospitals
  9.4.7.2 Clinics
  9.4.7.3 Research Institutions
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Electroconvulsive Therapy Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 ECT Devices
  9.5.4.2 Accessories
  9.5.4.3 Consumables
  9.5.5 Historic and Forecasted Market Size By Technology
  9.5.5.1 Unilateral ECT
  9.5.5.2 Bilateral ECT
  9.5.5.3 Others
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Major Depressive Disorder
  9.5.6.2 Bipolar Disorder
  9.5.6.3 Schizophrenia
  9.5.6.4 Others
  9.5.7 Historic and Forecasted Market Size By End User
  9.5.7.1 Hospitals
  9.5.7.2 Clinics
  9.5.7.3 Research Institutions
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
9.6. Middle East & Africa Electroconvulsive Therapy Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 ECT Devices
  9.6.4.2 Accessories
  9.6.4.3 Consumables
  9.6.5 Historic and Forecasted Market Size By Technology
  9.6.5.1 Unilateral ECT
  9.6.5.2 Bilateral ECT
  9.6.5.3 Others
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Major Depressive Disorder
  9.6.6.2 Bipolar Disorder
  9.6.6.3 Schizophrenia
  9.6.6.4 Others
  9.6.7 Historic and Forecasted Market Size By End User
  9.6.7.1 Hospitals
  9.6.7.2 Clinics
  9.6.7.3 Research Institutions
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
9.7. South America Electroconvulsive Therapy Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 ECT Devices
  9.7.4.2 Accessories
  9.7.4.3 Consumables
  9.7.5 Historic and Forecasted Market Size By Technology
  9.7.5.1 Unilateral ECT
  9.7.5.2 Bilateral ECT
  9.7.5.3 Others
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Major Depressive Disorder
  9.7.6.2 Bipolar Disorder
  9.7.6.3 Schizophrenia
  9.7.6.4 Others
  9.7.7 Historic and Forecasted Market Size By End User
  9.7.7.1 Hospitals
  9.7.7.2 Clinics
  9.7.7.3 Research Institutions
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
 

Electroconvulsive Therapy Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 16.1 Billion

Forecast Period 2024-32 CAGR:

2.60 %

Market Size in 2032:

USD 20.28 Billion

Segments Covered:

By Product Type

  • ECT Devices
  • Accessories
  • Consumables

By Technology

  • Unilateral ECT
  • Bilateral ECT
  • Others

By Application

  • Major Depressive Disorder
  • Bipolar Disorder
  • Schizophrenia
  • Others

By End User

  • Hospitals
  • Clinics
  • Research Institutions

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Advancements in ECT Technology

Key Market Restraints:

  • Stigma Surrounding Electroconvulsive Therapy

Key Opportunities:

  • Innovations in ECT Devices and Techniques

Companies Covered in the report:

  • Somatics, LLC (United States), Neurostar, Inc. (United States), Viva Healthcare (United States), MagVenture A/S (Denmark), Korea Electroconvulsive Therapy (South Korea), Ectron (United States), Bramsys (France), Demeditec Diagnostics GmbH (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Electroconvulsive Therapy Corporation (United States). and Other Active Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Electroconvulsive Therapy Market research report?

The forecast period in the Electroconvulsive Therapy Market research report is 2024-2032.

Who are the key players in the Electroconvulsive Therapy Market?

Somatics, LLC (United States), Neurostar, Inc. (United States), Viva Healthcare (United States), MagVenture A/S (Denmark), Korea Electroconvulsive Therapy (South Korea), Ectron (United States), Bramsys (France), Demeditec Diagnostics GmbH (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Electroconvulsive Therapy Corporation (United States).

What are the segments of the Electroconvulsive Therapy Market?

The Electroconvulsive Therapy Market is segmented into by Product Type (ECT Devices, Accessories, Consumables), Technology (Unilateral ECT, Bilateral ECT, Others), Application (Major Depressive Disorder, Bipolar Disorder, Schizophrenia, Others), End User (Hospitals, Clinics, Research Institutions). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).

What is the Electroconvulsive Therapy Market?

The Electroconvulsive Therapy (ECT) market includes the sale and usage of medical devices and therapeutic processes that deliver electric currents to the brain in order to manage several mental health disorders, but mainly MDD, Bipolar Disorder and Schizophrenia. ECT is commonly used as a last resort after a patient has not responded to medication or psychotherapy or when the patient needs to get well urgently. This method of treatment is conducted with certain restrictions and it is important for the fact that it effectively helps to lessen severe manifestations, thus enhancing the psychical well-being and the sphere of life of patients.

How big is the Electroconvulsive Therapy Market?

Electroconvulsive Therapy Market Size Was Valued at USD 16.1 Billion in 2023, and is Projected to Reach USD 20.28 Billion by 2032, Growing at a CAGR of 2.60% From 2024-2032.